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Three patients, with constitutional trisomy 8 mosaicism (CT8M), who developed a malignancy are reported. The diagnoses 
were refractory anaemia, acute lymphoblastic leukaemia, and idiopathic myelofibrosis. In the child with acute leukaemia, the 
CT8M was diagnosed at birth due to severe dysmorphisms and malformations; the other two patients showed a milder 
phenotype, and the CT8M was diagnosed only after the finding of trisomy 8 in neoplastic cells. The review of eight similar, 
previously reported cases and the clinical, cytogenetic, and molecular studies performed in our patients led us t o  make the 
following observations: (I) CT8M predisposes t o  neoplasms, preferentially to  myelo- or lymphoproliferative diseases; (2) a gene 
dosage effect for glutathione reductase in red blood cells was seen in two of our patients; (3) the wide phenotypic variation 
of CT8M was confirmed: trisomy 8 in neoplastic cells of phenotypically near-normal cases may be misinterpreted as acquired; 
and (4) molecular studies suggested a postzygotic origin of the trisomy in our three cases, with the supernumerary chromosome 
being of paternal origin in one case and of maternal origin in the other two. We postulate that the trisomy 8 in neoplasms may 
often occur by mitotic nondisjunction in an early embryonic multipotent cell and that what is usually interpreted as an acquired 
trisomy 8 may in fact be CT8M. The constitutional trisomy 8 would act as a pathogenetically important first mutation in 
multistep carcinogenesis. Whenever trisomy 8 is found in malignancies, the patient should be reevaluated clinically t o  exclude 
CT8M, and CT8M patients should be monitored for the possible development of malignancies. Genes Chromosom Concer 
17:94-101 (1996). 0 1996 Wiley-Lia, Inc. 
INTRODUCTION 
The  phenotype of constitutional mosaicism for 
trisomy 8 (CT8M) usually includes mental retarda- 
tion and dysmorphic features, but cases with a 
near-normal phenotype have also been reported 
(Chandley et al., 1980; Hasle e t  al., 1995). Ac- 
quired trisomy 8 is common in lympho- and my- 
eloproliferative disorders (Mitelman, 1991). We re- 
view the few reported patients with CT8M who 
have developed a malignancy and report three 
cases of CT8M associated with haematological dis- 
orders. 
MATERIALS AND METHODS 
Patients 
Case I 
P.A. is a boy who was born in 1984 with a birth 
weight of 2,850 g. At the age of 3 years, he pre- 
sented with petechiae and was treated with inter- 
mittent courses of corticosteroids. In October 1991, 
he was found to be anaemic and thrombocytopenic. 
His blood indices were 8.9 g/dl of haemoglobin 
(Hb), 2.4 x 10"/1 of red blood cells (RBC), and 4.7 
X 109/1 of white blood cells (WBC), with a normal 
differential count. Platelets were 11 X 109/1, and 
megathrombocytes were present. The  bone marrow 
was normocellular, with 2-3% blasts, normal my- 
elopoietic series, very few megakaryocytes, and se- 
vere anomalies of the erythroid series that was hy- 
perplastic with dyserythropoiesis, pycnotic nuclei, 
and cytoplasmic bridges. A diagnosis of refractory 
anaemia (RA) was made, and a chromosome anal- 
ysis revealed CT8M (Table 1). The  child's phe- 
notype was examined for signs of this constitutional 
condition. A few dysmorphic changes were found, 
namely, macrocephaly, hypertelorism, broad nose, 
highly arched palate, short and wide neck, vertebral 
anomalies, hypoplastic nipples, bilateral syndactily 
of the second and third toes, hypoplastic nails, and 
mobile testes (Fig. la). The  boy had slight mental 
retardation, with an IQ of 65 (normal values (n.v.) 
75-100). Behaviour and speech problems were ev- 
ident. In the following years, the haematological 
condition of the patient remained stable without 
need for therapy (June 1995). 
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TABLE I. Results of Chromosome Analyses 
Material Karyotype Case Date 
95 
I 22.10.9 I 
04.12.9 I 
14.04.92 
20.10.92 
15.06.93 
2 02.06.90 
21.01.91 
29.09.9 I 
3 22.0 I .93 
05.02.93 
05.10.93‘ 
BM” 
Fibroblasts 
BM 
BM 
PB 
PB 
BM 
Fibroblasts 
Fibroblasts 
BM 
PB-PHA 
PB-PHA 
PB-PHA 
47,XY, + 8[ I8]/46,XY[ I I J 
47,XY, + 8[23]/46,XY[27] 
46,XY[ I OOIb 
47,XY, + 8[ 33]/46,XY[37]c 
47,XY. + 8[ I9]/46,XY[ 31 
47,XY. + 8[ IO]/46,XY[6] 
47,XY, + 8[5]/46,XY[5] 
47,XY. + 8[ I 3]/46,XY[ I I ] 
47,XY. + 8[85]/46,XY[ 15) 
47,XY, + 8[5Jd 
47,XY, + 8[ 36]/46,XY[ 141‘ 
47,XX. + 8[ I 3]/46,XX[7] 
47,XX, + 8[ I8]/46,XX[ I 2 J 
chi47,XX, + 8[ 3]/46,XX[2]/46,XY[95] 
‘BM, bone marrow direct preparations and 24-h cultures; PB-PHA, peripheral-blood 
PHA-stimulated cultures; PB, peripheral-blood unstimulated cultures. 
bCells from first growth halo. 
Tells from second growth halo. 
dFISH on BM nuclei with centromere-&specific alphoid probe showed three signals in 
90% of 100 cells. 
‘FISH on fibroblast nuclei showed three signals in 64% of I50 cells. 
‘After allogeneic bone marrow transplantation performed in August 1993. 
Case 2 
E.M. is a boy who was born in 1990 with a birth 
weight of 3,560 g. At birth, an echoscan showed 
enlargement of the left renal pelvis and calyces, 
with stenosis of the junction to the ureter, and 
right-sided hydronephrosis with renal hypoplasia. 
These findings were confirmed by urography. 
X-ray examination showed diffuse condensing os- 
teopathy, 1-cm spondylolisis of the 1 l th  thoracic 
vertebra, short lower limbs, tubular bones with 
“bone-within-bone” appearance, iliac wing hy- 
poplasia, and supernumerary ribs. The  bone age 
was advanced (3 months). Electrocardiogram 
showed a slight biventricular hypertrophy. Recon- 
structive surgery permitted renal function. In Jan- 
uary 1991, his liver and spleen were enlarged (1 cm 
and 6 cm from costal margin, respectively), and 
blood indices were 8.3 g/dl of Hb, 3.47 X 10’2/1 of 
RBC, 15 X 109/1 of WBC, and 75 X 109/1 of plate- 
lets. The  bone marrow was almost monomorphic, 
with 94% L1-type blasts with a common immuno- 
logic phenotype (CD24 89%, CD9 75%, CDlO 
84%, OK DR 82%, CD38 68%, Cy Ig neg, CD20 
6%). Acute lymphoblastic leukaemia (ALL) was 
diagnosed. A marrow examination 1 month after 
the beginning of polychemotherapy showed nor- 
mal morphology and disappearance of blasts. 
The  child was reevaluated in April 1992 (Fig. 
lb,c). He was now hypotonic, did not walk, and 
psychomotor delay was evident. T h e  skin was pale 
with cutis marmorata. Craniofacial dysmorphisms 
included microcephaly (<3rd percentile), hyperte- 
lorism, micrognathia, everted and thick lower lip, 
large nose, horizontal dimple on the chin, and low- 
set ears. We observed a short and wide neck, nar- 
row shoulders, long trunk, kyphoscoliosis with dor- 
sal boss, funnel chest with pectus excavatum, short 
hands with deep palmar furrows and nail dysplasia, 
genu valgum and pes valgus, camptodactily of the 
2nd left toe, very deep plantar furrows, and hypo- 
spadia. The  liver and spleen were still slightly en- 
larged. 
Case 3 
V. R. is a woman who was born in 1964. Although 
she presented with slight mental retardation, she 
attended and finished primary school. Since the 
age of 12 years, she has had regular menses. In 
January 1989, a macrocytic anaemia (Hb 9.7 g/dl) 
was found, and treatment with vitamins was inef- 
fective. In December 1992, the anaemia worsened, 
and her blood indices showed 5.6 g/dl of Hb, 6 x 
109/1 of WBC with 33% lymphocytes, 52% neutro- 
phils, and 15% blasts. T h e  blasts (alkaline phos- 
phatase and CD34 positive) were large, with a high 
nucleus/cytoplasm ratio. The  cytoplasm was baso- 
philic, with fine azurophilic granules, and anisopoi- 
kilocytosis was present. T h e  bone marrow was hy- 
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Figure I. a: Phenotype of case I, aged 7 years. b.c: Face and left foot of case 2, aged 2 years. d,e: Face 
and left foot of case 3, aged 28 years. 
percellular (85-90%), with hyperplasia of the 
granulocytic and megakaryocytic series. The  gran- 
ulocytic series showed various steps of develop- 
ment; the megakaryocytes were in clusters and 
dystrophic. T h e  number of erythroid cells was de- 
creased, and only normoblasts and proerythroblasts 
were observed. Stromal cells were diffusely abun- 
dant, with some lymphoid reactive clusters. A di- 
agnosis of idiopathic myelofibrosis was made, and 
she was treated only with transfusions. Attempts to 
obtain cytogenetic results on bone marrow samples 
failed, but the karyotype from stimulated blood 
cultures revealed a CT8M. The  phenotype was 
reevaluated in view of the constitutional anomaly 
and showed a few dysmorphic changes: moderate 
palpebral ptosis and strabismus, horizontal dimple 
on the chin, everted lower lip, highly arched pal- 
ate, wide neck, narrow shoulders and long trunk, 
dorsolumbar kyphoscoliosis, one supernumerary 
nipple, clinodactily of the 5th finger, hallux valgus, 
sandal gap of toes, hammer toes, and deep palmar 
and plantar furrows (Fig. ld,e). Gastric hypotonia 
with slow peristalsis and ptosis of the transverse 
colon was found, but without organic lesions. T h e  
IQ was 83 (n.v. 90-100). At the end of August 
1993, she received a bone marrow transplant from 
her HLA-identical brother. She died of interstitial 
pneumonia in March 1994. 
Cytogenetic Methods 
Patients 1 and 3 were first investigated at the 
moment of diagnosis of their haematological disor- 
ders on bone marrow and on stimulated peripheral 
blood cultures. In patient 2, a stimulated blood 
culture was performed at birth, and a chromosome 
analysis was repeated on bone marrow when ALL 
was diagnosed. In addition, CT8M was checked on 
fibroblast cultures from skin biopsies from all of the 
patients. Clones were established from fibroblasts 
and used for molecular studies only after at least 50 
mitoses showed a nonmosaic karyotype. 
Chromosome analyses were performed according 
to standard techniques, and the karyotypes for all 
of the patients were analyzed by QFQ and GTG 
banding. 
Biochemical Methods 
Glutathione reductase (GSR), which maps to 
8p12 (Oshima et al., 1994), was assayed in RBC 
from patients 1 and 2 and from their parents by the 
method of George and Francke (1976), with minor 
modifications. T h e  results of enzyme determina- 
tions are expressed as ratios between the activities 
of propositi and the mean of their parents’ activities 
(Rts) to minimize the relevance of individual vari- 
ations. 
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Figure 2. Results of STR analyses in the three patients and their 
parents. Loci tested are listed after their map order; exact localization is 
shown only for some of them. The results obtained for each locus are 
entered with letters, the letter a being the allele with the lowest mo- 
lecular weight. Columns headed by the number 46 refer to cloned 
The  results were compared with a group of con- 
trols and with a group of patients with constitu- 
tional duplication of the region of chromosome 8 
which includes the gene for GSR. 
Peptidase A (PEPA) and malate dehydrogenase 
(MDHl), whose genes are mapped on chromo- 
somes 18 and 2, respectively, were tested as con- 
trol enzymes. 
Molecular Methods 
T o  determine the origin of the extra chromo- 
some 8, we performed a molecular analysis of 13 
short tandem repeats (STR) scattered along chro- 
mosome 8 on DNA from the 46 and 47 cloned 
fibroblasts of the three patients and from periph- 
eral WBC of their parents. In addition, WBC were 
tested in patients 1 and 3. The  STR were chosen 
among those with high heterozygosity and are 
listed in Figure 2. Methods for polymerase chain 
reaction (PCR) amplification and product detection 
were described elsewhere (Floridia et al., 1996). 
RESULTS 
Cytogenetic Results 
The  results are listed in Table 1 .  In case 1 ,  the 
trisomic line in fibroblasts was observed only on a 
46 47 
bc. bc, bbc. ab 
bc. ac, ac, aa 
ab. bb. bb, bc 
bd. bc. bc, ac 
as. ac* acc. bc 
ac. ab. abb. ab 
aa. ab. abb. ab 
bb, bb, bb, ab 
ac. bc, bc. bd 
ac, bc, bc. bd 
ab, aa, aa, aa 
bc, ab, ab, ac 
cc, bc, bc, ab 
Case 2 
46 47 PB 
bb. ab. dab, aab 
ab, ac, ac, ac 
aa, aa, aa, aa 
ab, ab, aab, dab 
aa, aa, aa. a a  
ab, ab, abb, ab 
ad. ab. abb, abb 
ab. ab, ab, ab 
aa, aa, aa, aa 
aa, ab, ab, ab 
bb. ab. dab. dab 
bc. ac, aac, aac 
ab, ab, ab, ab 
Case 3 
diploid fibroblasts, those by the number 47 to cloned trisomic 8 fibro- 
blasts, and PB indicates analysis on WBC. Evidence of duplication of one 
allele is indicated by three letters. Results informative for parental origin 
of the supernumerary chromosome are in boldface. 
second chromosome preparation made on the sec- 
ond growth halo from skin fragments. In case 2, the 
presence of trisomy 8 in bone marrow and skin 
fibroblasts was also demonstrated with interphase 
cytogenetics (FISH with a centromere-8-specific 
alphoid probe). 
Gene Dosage Studies 
T h e  results of the assays for GSR, PEPA, and 
MDHl are listed in Table 2. In the control group, 
the Rts were found very close to the expected ones 
for all enzymes. 
The  patients with constitutional duplication of at 
least 8p12 showed increased Rts for GSR when 
compared with controls (t = 8.34, p < 0.001), cor- 
responding to a gene dosage effect. 
In patients 1 and 2, the Rts for the control en- 
zymes was normal, whereas the one for GSR was 
increased (Table 2). In case 1, the Rts for GSR was 
intermediate between controls (2 alleles) and pa- 
tients with 8p duplications (3 alleles). T h e  value 
found could be obtained if 50% of the RBC were 
derived from cells with three alleles, which is in 
agreement with the mosaic status of the patient in 
the various tissues studied (Table 1). 
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TABLE 2. Results of Gene Dosane Studiesa 
GSR PEPA MDH I 
Controls I .07 f 0. I4 0.92 f 0. I9 0.99 k 0. I I 
(4 (16) 
dUP(8P) I .76 & 0.29 
0.86 - (4 (12) Case I I .45 
Case 2 2.34 - 1.15 
(10) - ( 1  1 )  - 
The  figures refer to ratio between the enzymatic activity of the child 
and the mean of the activities of his parents (Rts). The expected Rts for 
normal subjects is I .  
In case 2 ,  the Rts was similar to the highest 
values found in dup(8p) patients (Table 2 ) ,  which 
agrees with the higher percentage of trisomic cells 
observed (Table 1). 
Case 3 was not tested because of the frequent 
blood transfusions. 
Molecular Results 
All the results are entered in Figure 2 and par- 
tially shown in Figure 3. When comparing allelic 
data on the cloned fibroblasts for each patient, we 
found the same alleles in cells with and without 
trisomy 8. We never observed three different alle- 
les in the 47 cell line. At least three of the STR 
showed a clear difference in the intensity of the 
two alleles in the trisomic cells of each of the pa- 
tients (Fig. 3), which we interpret as evidence of 
duplication of this allele (Fig. 2 ) .  The  alleles show- 
ing increased intensity were consistently paternal 
in origin in case 1 and maternal in origin in cases 2 
and 3 (Figs. 2, 3). Analysis of additional control 
autosomal STR (D4S2361, D6S1003, D15S822, 
D13S782) demonstrated the presence of the ex- 
pected paternal or maternal (cases 1 and 2) and 
paternal (case 3) alleles (data not shown). 
DISCUSSION 
The  risk of neoplasms in patients with constitu- 
tional chromosome anomalies is well known for tri- 
somy 21 (Sandberg, 1991) and was discussed for 
other anomalies by Alimena et al. (1985) and Hecht 
(1987), who, however, did not study any CT8M 
case. We found eight reports of single cases of pa- 
tients with CTSM who developed a neoplasm, and 
these are listed in Table 3 with the three present 
cases. 
Does CT8M predispose to neoplasms and, in 
particular, to myelo- or lymphoproliferative disor- 
ders? Cancer is the result of the accumulation of 
different genetic lesions as activation of proto-on- 
cogenes, inactivation of tumor suppressor genes, or 
chromosome abnormalities. T h e  molecular signifi- 
cance of many of these abnormalities is not known, 
but they are very frequent in some tumor types 
(Solomon et al., 1991; Heim, 1992), as is the case 
with trisomy 8. The  fact that trisomy 8 cells are 
present in various tissues in CT8M, e.g., in the 
bone marrow, could predispose to malignant trans- 
formation. This action is similar to that of retinal 
cells bearing a heritable mutation of the RBI gene, 
which makes them prone to develop retinoblas- 
toma (Knudson, 1971). 
T h e  exact prevalence of CT8M is not known but 
is certainly low. Procter et al. (1984) stated that 
fewer than 100 cases had been reported. Nielsen 
and Wohlert (1991) found 1 case out of 34,910 new- 
borns; we found 2 out of 40,140 routine chromo- 
some analyses; Hecht and Hecht (1987) mentioned 
that no case had been found in 64,887 liveborns; 
and Hasle et al. (1995) estimated a prevalence of 1 
in 25,000. In comparison with these numbers, the 
fact that we are aware of 1 1  cases of CTSM who 
developed a malignancy (Table 3) cannot be a co- 
incidence. Therefore, we postulate that CT8M 
predisposes to neoplasms. 
T h e  study of GSR activity in patients 1 and 2 
demonstrated, as expected, a gene dosage effect 
(Table 2 ) .  An increased activity of GSR was al- 
ready reported in acquired trisomy 8 by de la 
Chapelle et al. (1978) and Sadamori et al. (1983). 
Three relevant points should be mentioned. First, 
trisomy 8 is detectable indirectly through gene dos- 
age studies in cells such as RBC, where chromo- 
some analyses cannot be made. This fact may help 
studies in lineage involvement. Second, it is pos- 
sible to correlate the level of activity to the relative 
proportions of disomic and trisomic cells (Tables 1, 
2). Third, the effect of an acquired trisomy on the 
neoplastic cell phenotype is mediated by increased 
dosage of gene products whose loci are on the in- 
volved chromosome. Therefore, gene dosage stud- 
ies may explain some features of the neoplastic 
cell, as was suggested for monosomy 7 (Minelli et 
al., 1990). 
A peculiar observation was made during fibro- 
blast analysis of patient 1. T h e  karyotype was nor- 
mal in 100 mitoses from the first growth halo from 
skin fragments, whereas the second growth from 
the same fragments showed 33 trisomic cells out of 
70 analysed (Table 1).  We have no explanation for 
this unexpected finding. 
T h e  wide variation of phenotypes in CT8M has 
been discussed (Chandley et al., 1980; Camurri 
and Chiesi, 1991; Kapaun et al., 1993; McDonald- 
CONSTITUTIONAL TRlSOMY 8 AND NEOPLASMS 
Case 1 Case 2 Case 3 
T O  T __ nT--p 
46 47 PB 46 47 46 47 PB 
99 
D8S84 D8S165 D8S198 
D8S552 D8S261 D8S85 
Figure 3. Examples of results obtained in STR analysis of the three 
patients and their parents. Headings of lanes as in Figure 2 In case I, the 
intensity of the paternal allele appears stronger than the maternal one 
for both loci in the 47 cells and in PB. A similar difference of intensity of 
the two alleles in 47 and PB cells is shown for both loci of cases 2 and 
3, in whom the maternal allele is stronger. 
McGinn et al., 1993; Hasle et al., 1995; Mark et 
al., 1995). Schinzel (1994) listed 46 signs found in 
at least 10% and 19 found in at least 20% of 102 
cases of CT8M. Some of these signs were seen also 
in our patients; case 2 presented the most signs and 
he was the only one with CT8M diagnosed before 
the neoplastic disorder. Only three manifestations 
were common to our three patients, namely mental 
retardation, short neck, and scoliosis. Dysmor- 
phisms such as narrow shoulders, hypoplastic nails, 
hallux valgus, and supernumerary nipples, which 
may be expected and were present in our cases, are 
easily overlooked. Thus, the phenotype of CT8M 
can escape recognition, as happened in our cases 1 
and 3, because the manifestations may be minor. 
Even mental retardation is present in only 71% of 
cases (Schinzel, 1994). 
Haas and Seyger (1993) postulated that some of 
the trisomies of neoplasms may originate during 
meiosis, leading to a constitutional mosaic with the 
trisomic line limited to neoplastic cells. We knew 
from fibroblast analyses that the trisomy in our 
cases was constitutional, and we tried to demon- 
strate the meiotic origin of the extra chromosome 
8. When analysing molecular polymorphisms with 
this aim, the trisomic cell line is expected to show 
both alleles of the heterozygous parent contribut- 
ing the supernumerary chromosome (nonreduction 
to homozygosity) or only one of them (reduction to 
homozygosity) in various combinations for the dif- 
ferent loci, depending on a meiosis 1 or meiosis 2 
nondisjunction and on possible crossing-over 
events (Antonarakis et al., 1993). If a meiotic error 
occurred, then the 46 cell line would originate by 
loss of the supernumerary chromosome, resulting 
in uniparental disomy in one-third of cases. 
We never observed three different alleles at any 
of the loci analysed (Fig. 2). In 13 instances, allele 
distribution of cases 1 and 2 excluded the presence 
of two different alleles contributed by either par- 
ent. In case 3, where only paternal DNA was avail- 
able, we never observed evidence of two different 
nonpaternal alleles, and two loci showed only one 
of the two paternal alleles. Paternal and maternal 
contributions were present in the 46 cell lines of 
the three patients. 
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TABLE 3. CT8M Cases Associated With Neoplasms 
Tissues with 
detected 
Reference Ageisex Phenotype Diagnosisa trisomy 8b 
Gafter et al. (1976) 
Riccardi et al. ( I  978) 
Cornaglia-Fertaris et al. ( I  981) 
Palmer et al. ( I  983) 
Lessick et al. ( I  990) 
Kapaun et al. ( I  993) 
Hasle et al. ( I  995) 
Mark et al. (1995) 
Present case I 
Present case 2 
Present case 3 
40/F 
40/M 
5/M 
2/M 
6/M 
I7/F 
I I IM 
42/F 
7/M 
I IM  
28/F 
Abnormal 
Normal 
Abnormal 
Abnormal 
Abnormal 
Near normal 
Normal 
Normal 
Mild 
Abnormal 
Mild 
MDS ANLL 
ANLL 
MDS‘ 
MDS 
LMS 
MDS 
MDS 
P S W  
MDS 
IM 
ALL-L I 
PB 
BM, SF 
PB 
BM, PB, SF 
PB, LMS cells 
BM, PB, SF 
BM, PB, SF 
SF, PSTT cells 
BM, PB, SF 
BM, PB, SF 
BM, PB, SF 
’MDS, myelodysplastic syndrome (includes disorders such as “aplastic anaemia followed by acute leukaemia”, Gafter et 
al., 1976, “juvenile chronic granulocytic leukaemia”, Palmer et al.. 1983. “atypical Ph-negative chronic myelogenous 
leukaemia”. Kapaun et al.. 1993, and “refractory anaemia with excess of blasts”, Hasle et al., 1995); ANLL, acute 
nonlymphocytic leukaemia; LMS, leiomyosarcoma; PSST, placental site trophoblastic tumor; ALL-L I, acute lymphoblastic 
leukaemia of LI -type FAB IM, idiopathic myelofibrosis. 
bPB, peripheral blood; BM, bone marrow; SF, skin fibroblasts. 
‘MDS is not in fact diagnosed in this case but only suspected on the basis of in vitro colony-forming capacity of BM cells. 
dThe interpretation of this case is controversial. CTBM is present in this woman and demonstrated by SF chromosome 
analysis, whereas PSlT is a tumor originating in trophoblastic cells, that is, cells of embryonic origin; trisomy 8. however, 
is also present in there tumor cells. 
Thus, we failed to obtain any evidence of a mei- 
otic error, and the best explanation of our data is a 
mitotic postzygotic nondisjunction. 
Evidence for paternal or maternal origin of the 
supernumerary chromosome 8 was inferred by the 
uneven intensity of the alleles in the trisomic 
clones of the three patients (Figs. 2, 3). No differ- 
ence in intensity was observed in the 46 clones. In 
peripheral blood, where a mixture of 46 and 47 
cells was present and at least 50% of the meta- 
phases showed trisomy 8 (Table l) ,  we observed 
results similar to those of cloned 47 fibroblasts, 
with the exception of a single marker (ANK) in 
case 3 (Fig. 2). 
We are well aware of the caution that must be 
used in quantitative interpretation of PCR results. 
However, because the more intense band could be 
consistently referred to the father in case 1 and to 
the mother in cases 2 and 3, we interpreted these 
findings as evidence of duplication of paternal and 
maternal alleles, respectively. Robinson et al. 
(1995) identified a paternal origin in two other 
cases of CT8M with the same method. Therefore, 
a random occurrence of parental origin seems to be 
present in the five cases of CT8M studied so far, as 
in the postzygotic trisomy 21 mosaics studied by 
Antonarakis et al. (1993). 
We differ somewhat with the hypothesis by Haas 
and Seyger (1993) in that the origin of trisomy 8 in 
neoplasms is not necessarily meiotic but may often 
be mitotic-postzygotic. T h e  point is that, whatever 
the origin, what is usually thought to be acquired 
trisomy 8 may in fact be a CT8M. This may arise 
from a postzygotic mitotic nondisjunction in an 
early embryonic multipotent cell, from which dif- 
ferent tissues may originate, instead of a cell of an 
already differentiated tissue, as would be true of 
bone marrow when trisomy 8 is associated with 
myeloproliferative disorders. Thus, the neoplastic 
risk of CT8M would be explained by the constitu- 
tional presence of a primary chromosome mutation. 
Our results support this hypothesis because we 
observed trisomy 8 in different cell types of our 
patients, such as fibroblasts, WBC, and RBC (as 
deduced by gene dosage of GSR), and our molec- 
ular analysis fits with a postzygotic origin of the 
CT8M. 
The  presence of trisomy 8 in nonmyeloid cells in 
a case of acute myeloid leukaemia was reported by 
El-Rifai et al. (1996), who also found it in lympho- 
cytes and discussed its relevance in the develop- 
ment of leukaemia. No further data are provided to 
reveal whether this case might in fact be a CT8M. 
It is relevant that 9 of 11 cases of CT8M listed in 
Table 3 developed haematologic disorders in 
which a trisomy 8 is frequent. Of the two solid 
tumors, one is a leiomyosarcoma, a neoplasm in 
which trisomy 8 has been found as an acquired 
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anomaly, although not among the most frequent 
ones (Sandberg and Bridge, 1994). No consistent 
cytogenetic data are available for PSTT (Table 3). 
The  variable phenotype of CTSM may be re- 
sponsible for the failure of recognition in near-nor- 
ma1 or mild cases; when such cases in turn develop 
a neoplasm, the trisomy 8 in neoplastic cells is 
thought to be acquired. We stress the fact that 6 of 
the 11 cases listed in Table 3 were found to be 
CT8M only after the demonstration of a trisomy 8 
in neoplastic cells. 
In conclusion, we suggest that, when a trisomy 8 
is found in neoplastic cells, the patient should be 
reevaluated clinically to check for the possibility of 
a CTSM, and, conversely, that when a CT8M is 
diagnosed the patient should be accurately ob- 
served for the risk of neoplasms and, in particular, 
of haematological neoplasms. 
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